Picture of Hyphens Pharma International logo

1J5 Hyphens Pharma International Cashflow Statement

0.000.00%
sg flag iconLast trade - 00:00
HealthcareBalancedSmall CapSuper Stock

Annual cashflow statement for Hyphens Pharma International, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line7.118.2614.310.613
Depreciation
Amortisation
Non-Cash Items-0.1880.457-0.127-0.8790.887
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-4.87-4.88-0.009-6.84-16.8
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities4.136.0416.95.640.06
Capital Expenditures-1.2-0.835-1.31-1.2-3.18
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.187-14.10.308-0.280.16
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-1.01-14.9-1.01-1.48-3.02
Financing Cash Flow Items-0.11-0.0955.86-0.278-0.438
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1.760.8141.15-17.33.01
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.36-8.0617-13.10.051